Mercury Laboratories Limited (BOM:538964)
India · Delayed Price · Currency is INR 833.00
+17.95 (2.20%)
At close: Sep 25, 2026
Mercury Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,000 | 840 | 983 | 999 | 702 | 582 | |
Market Cap Growth | -4.80% | -14.54% | -1.57% | 42.14% | 20.70% | -24.52% |
Enterprise Value | 1,022 | 872 | 1,002 | 1,000 | 690 | 579 |
Last Close Price | 833.00 | 696.86 | 812.09 | 822.15 | 575.83 | 474.21 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 24.01 | 17.38 | 31.25 | 17.66 | 12.59 | 16.34 |
PS Ratio | 1.36 | 1.11 | 1.31 | 1.32 | 0.93 | 1.00 |
PB Ratio | 1.72 | 1.45 | 1.84 | 1.96 | 1.54 | 1.44 |
P/TBV Ratio | 1.72 | 1.45 | 1.84 | 1.97 | 1.54 | 1.45 |
P/FCF Ratio | 93.01 | 78.16 | - | 51.12 | 50.34 | 17.77 |
P/OCF Ratio | 23.58 | 19.81 | 20.23 | 12.14 | 28.65 | 11.22 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.39 | 1.15 | 1.33 | 1.32 | 0.92 | 1.00 |
EV/EBITDA Ratio | 12.33 | 9.97 | 14.90 | 11.55 | 8.20 | 8.59 |
EV/EBIT Ratio | 22.35 | 14.51 | 22.37 | 15.29 | 10.90 | 12.36 |
EV/FCF Ratio | 95.10 | 81.12 | - | 51.21 | 49.42 | 17.68 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.10 | 0.11 | 0.13 | 0.15 |
Debt / EBITDA Ratio | 1.02 | 0.90 | 0.74 | 0.59 | 0.66 | 0.84 |
Debt / FCF Ratio | - | 7.84 | - | 2.84 | 4.18 | 1.83 |
Net Debt / Equity Ratio | 0.04 | 0.05 | 0.07 | -0.05 | -0.02 | -0.01 |
Net Debt / EBITDA Ratio | 0.27 | 0.33 | 0.58 | -0.29 | -0.12 | -0.04 |
Net Debt / FCF Ratio | - | 2.70 | -0.93 | -1.30 | -0.73 | -0.08 |
Asset Turnover | - | 0.99 | 1.06 | 1.14 | 1.19 | 0.91 |
Inventory Turnover | - | 4.35 | 4.53 | 4.95 | 4.81 | 4.15 |
Quick Ratio | - | 2.69 | 1.81 | 2.38 | 1.99 | 1.46 |
Current Ratio | - | 3.85 | 2.60 | 3.15 | 2.78 | 2.24 |
Return on Equity (ROE) | - | 8.66% | 6.02% | 11.72% | 12.98% | 9.23% |
Return on Assets (ROA) | - | 4.90% | 3.94% | 6.19% | 6.25% | 4.58% |
Return on Invested Capital (ROIC) | 5.73% | 7.39% | 5.71% | 11.51% | 11.20% | 8.30% |
Return on Capital Employed (ROCE) | - | 8.90% | 7.60% | 11.80% | 12.70% | 10.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.17% | 5.75% | 3.20% | 5.66% | 7.94% | 6.12% |
FCF Yield | 1.08% | 1.28% | -4.25% | 1.96% | 1.99% | 5.63% |
Dividend Yield | 0.42% | 0.50% | 0.43% | 0.43% | 0.61% | 0.74% |
Payout Ratio | - | 8.69% | 13.36% | 7.43% | 7.53% | 6.74% |
Total Shareholder Return | 0.45% | 0.50% | 0.43% | 0.43% | 0.61% | 0.74% |